Envision Healthcare (NYSE:EVHC) has been assigned an average rating of “Hold” from the seventeen analysts that are covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $40.61.
Several research firms have weighed in on EVHC. Royal Bank of Canada reaffirmed a “buy” rating and issued a $48.00 price target on shares of Envision Healthcare in a report on Thursday, March 1st. Mizuho set a $35.00 price target on Envision Healthcare and gave the company a “hold” rating in a report on Wednesday, January 24th. SunTrust Banks raised their price target on Envision Healthcare to $45.00 and gave the company a “buy” rating in a report on Thursday, March 1st. Piper Jaffray began coverage on Envision Healthcare in a report on Wednesday, December 13th. They issued a “neutral” rating and a $35.00 price target on the stock. Finally, Cantor Fitzgerald raised their price target on Envision Healthcare from $37.00 to $40.00 and gave the company a “neutral” rating in a report on Wednesday, February 28th.
EVHC traded down $1.11 during trading on Wednesday, reaching $37.79. 2,066,619 shares of the company were exchanged, compared to its average volume of 2,354,322. The stock has a market capitalization of $4,703.98, a price-to-earnings ratio of 15.24, a price-to-earnings-growth ratio of 0.90 and a beta of 0.42. The company has a debt-to-equity ratio of 0.87, a quick ratio of 3.38 and a current ratio of 3.40. Envision Healthcare has a 12-month low of $23.77 and a 12-month high of $64.00.
Envision Healthcare (NYSE:EVHC) last released its quarterly earnings results on Tuesday, February 27th. The company reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.14. Envision Healthcare had a positive return on equity of 4.62% and a negative net margin of 2.52%. The firm had revenue of $2 billion for the quarter, compared to analysts’ expectations of $1.97 billion. During the same quarter last year, the firm posted $1.15 EPS. The company’s revenue was up 68.0% compared to the same quarter last year. research analysts forecast that Envision Healthcare will post 3.34 earnings per share for the current fiscal year.
Institutional investors and hedge funds have recently bought and sold shares of the stock. BlackRock Inc. grew its position in Envision Healthcare by 6.5% during the 4th quarter. BlackRock Inc. now owns 8,028,329 shares of the company’s stock worth $277,462,000 after acquiring an additional 487,314 shares during the last quarter. Wells Fargo & Company MN grew its position in Envision Healthcare by 11.2% during the 3rd quarter. Wells Fargo & Company MN now owns 917,418 shares of the company’s stock worth $41,238,000 after acquiring an additional 92,339 shares during the last quarter. Ares Management LLC bought a new position in Envision Healthcare during the 4th quarter worth approximately $752,000. OZ Management LP bought a new position in Envision Healthcare during the 3rd quarter worth approximately $131,987,000. Finally, Hexavest Inc. grew its position in Envision Healthcare by 1.1% during the 4th quarter. Hexavest Inc. now owns 655,516 shares of the company’s stock worth $22,655,000 after acquiring an additional 7,270 shares during the last quarter.
TRADEMARK VIOLATION WARNING: This piece of content was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international copyright & trademark law. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/04/07/envision-healthcare-evhc-receives-40-61-consensus-pt-from-brokerages.html.
About Envision Healthcare
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.